Discovery of FOXR2 activation in various brain tumors refines diagnosis to improve care

Physicians classify brain tumors and determine treatment options, in part, by the genes they express. According to World Health Organization standards, the abnormal activation of oncogene FOXR2 only occurs in central nervous system (CNS) neuroblastoma, but that may not be true. Findings from St….

Click here to view the original article.